Cognitive behaviour therapy for epilepsy: improving seizure control and quality of life
ISRCTN | ISRCTN31786019 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN31786019 |
Secondary identifying numbers | 1.0 |
- Submission date
- 26/11/2008
- Registration date
- 10/12/2008
- Last edited
- 07/08/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Laura H Goldstein
Scientific
Scientific
Department of Psychology
Institute of Psychiatry
King's College London
PO77
De Crespigny Park
London
SE5 8AF
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Cognitive behaviour therapy for epilepsy: improving seizure control and quality of life - a pilot randomised controlled trial |
Study objectives | This is a pilot/feasibility study investigating the use of cognitive behaviour therapy (CBT) plus standard medical care vs standard medical care alone in improving seizure control and quality of life in adults with refractory epilepsy. Specifically this feasibility study will enable us to: 1. Evaluate the applicability of our CBT techniques to a broader sample of patients than in our previous work 2. Determine the acceptability of this randomisation and treatment approach in a sample of patients attending specialist epilepsy clinics, thereby informing recruitment rates when designing a later, larger randomised controlled trial (RCT) 3. Obtain information on treatment effect sizes to undertake power calculations for a larger RCT |
Ethics approval(s) | Joint South London and Maudsley and the Institute of Psychiatry NHS Research Ethics Committee, 04/07/2008, ref: LREC 08/H0807/44 |
Health condition(s) or problem(s) studied | Epilepsy |
Intervention | Following baseline recording of seizure frequency participants will be randomly assigned to one of two arms: CBT (plus standard medical care): CBT will comprise 12 weekly/fortnightly individual therapy sessions with the CBT therapist, over 4 months. Treatment will follow our prepared treatment manual, with homework tasks and seizure recordings reviewed at each session. In addition to seizure-specific interventions (e.g. development of countermeasures), more general cognitive behavioural therapeutic techniques will be employed to address the management of times of increased vulnerability to seizures and to improve patientsÂ’ overall physical and emotional well-being, with a view to relapse prevention. Handouts will be given to participants. Standard medical care: Participants will be seen by their epilepsy specialist in their regular clinic, depending on clinical need. As with the CBT group, we will monitor the number of appointments that participants have with their epilepsy specialist over the 4-month period and whether any medication changes are implemented during that time. |
Intervention type | Other |
Primary outcome measure | Monthly seizure frequency, monitored throughout the study. Total duration of follow-up: 12 weeks. |
Secondary outcome measures | 1. Liverpool Seizure Severity Scale at baseline, 8 and 12 weeks 2. Hospital Anxiety and Depression Scale at baseline, 8 and 12 weeks 3. Quality of Life in Epilepsy Inventory-31 (QOLIE-31) at baseline, 8 and 12 weeks 4. Health service usage for previous 8 weeks, assessed using the Client Service Receipt Inventory (CSRI) at baseline, beginning of treatment, 8-week follow-up and for previous 4 weeks at 12 week follow up 5. Health status, assessed by Euroqol EQ-5D at baseline, 8 and 12 weeks |
Overall study start date | 01/12/2008 |
Completion date | 31/03/2010 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 65 Years |
Sex | Both |
Target number of participants | 40 |
Total final enrolment | 26 |
Key inclusion criteria | 1. Both males and females, age 18-65 years 2. Clinical diagnosis (with supporting electroencephalography [EEG]) of epilepsy 3. A maximum of 40 seizures/month involving alteration/loss of consciousness (i.e. complex partial or generalised seizures) with no limit to simple partial seizure frequency 4. Stable medication for the month prior to recruitment 5. Able to attend weekly/fortnightly sessions 6. Willing to complete questionnaires regularly to monitor progress |
Key exclusion criteria | 1. History of, or current actual/suspected non-epileptic seizures 2. <2 seizures per month in each of the preceding four months 3. Active major psychiatric disorder 4. Drug/alcohol dependence 5. Receiving active vagus nerve stimulation (VNS) for seizures that has been adjusted within the previous 12 months 6. Insufficiently fluent in English to be able to undertake treatment and complete questionnaires without the assistance of an interpreter 7. Established learning disability (or where this has been measured formally, IQ <70) |
Date of first enrolment | 01/12/2008 |
Date of final enrolment | 31/03/2010 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Department of Psychology
London
SE5 8AF
United Kingdom
SE5 8AF
United Kingdom
Sponsor information
Institute of Psychiatry, King's College London (UK)
University/education
University/education
c/o Mrs G Lambert
Research Governance/Clinical Trials Facilitator IoP/SLaM
R&D Office
PO05
De Crespigny Park
London
SE5 8AF
England
United Kingdom
Website | http://www.kcl.ac.uk |
---|---|
https://ror.org/0220mzb33 |
Funders
Funder type
Charity
Epilepsy Research UK (UK) (ref: P0805)
Private sector organisation / Other non-profit organizations
Private sector organisation / Other non-profit organizations
- Alternative name(s)
- ERUK
- Location
- United Kingdom
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Basic results | 07/07/2017 | 07/08/2020 | No | No |
Additional files
- ISRCTN31786019_BasicResults_07Jul2017.pdf
- uploaded 07/08/2020
Editorial Notes
07/08/2020: The basic results of this trial have been uploaded as an additional file.
11/05/2016: No publications found, verifying study status with principal investigator.